- Home
- CPS vs SVRA Comparison
CPS vs SVRA Comparison
Compare CPS & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- SVRA
- Stock Information
- Founded
- CPS 1960
- SVRA 2007
- Country
- CPS United States
- SVRA United States
- Employees
- CPS N/A
- SVRA N/A
- Industry
- CPS Auto Parts:O.E.M.
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- CPS Consumer Discretionary
- SVRA Health Care
- Exchange
- CPS Nasdaq
- SVRA Nasdaq
- Market Cap
- CPS 462.2M
- SVRA 527.2M
- IPO Year
- CPS N/A
- SVRA N/A
- Fundamental
- Price
- CPS $38.94
- SVRA $3.60
- Analyst Decision
- CPS Hold
- SVRA Buy
- Analyst Count
- CPS 1
- SVRA 8
- Target Price
- CPS $12.00
- SVRA $6.63
- AVG Volume (30 Days)
- CPS 231.1K
- SVRA 1.7M
- Earning Date
- CPS 10-30-2025
- SVRA 11-11-2025
- Dividend Yield
- CPS N/A
- SVRA N/A
- EPS Growth
- CPS N/A
- SVRA N/A
- EPS
- CPS 1.65
- SVRA N/A
- Revenue
- CPS $2,719,148,000.00
- SVRA N/A
- Revenue This Year
- CPS $2.31
- SVRA N/A
- Revenue Next Year
- CPS $3.69
- SVRA N/A
- P/E Ratio
- CPS $23.39
- SVRA N/A
- Revenue Growth
- CPS N/A
- SVRA N/A
- 52 Week Low
- CPS $10.38
- SVRA $1.89
- 52 Week High
- CPS $40.67
- SVRA $4.70
- Technical
- Relative Strength Index (RSI)
- CPS 70.90
- SVRA 64.24
- Support Level
- CPS $37.26
- SVRA $3.47
- Resistance Level
- CPS $40.67
- SVRA $3.72
- Average True Range (ATR)
- CPS 1.54
- SVRA 0.18
- MACD
- CPS -0.34
- SVRA -0.03
- Stochastic Oscillator
- CPS 66.28
- SVRA 52.80
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.